From 2018 to 2023, the number of concierge and direct primary care practices grew, and there was a substantial shift away from independent ownership. | The number of concierge and direct primary care ...

Setrusumab is a monoclonal antibody that inhibits sclerostin, a protein that negatively regulates bone development, allowing for new bone formation.

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...

A new study found that there has been a massive increase in direct primary care and concierge care practice models.

Song estimated that while concierge medicine and DPC practices likely make up between 10 and 20 percent of primary care ...

The number of concierge and direct primary care practices are rapidly rising across the United States, highlighting a ...

Mereo BioPharma (MREO) announced results from the Phase 3 ORBIT and COSMIC studies for setrusumab in Osteogenesis Imperfecta. Neither study ...

A new University of Oxford-led study, published in The Lancet Planetary Health, is the first to link daily temperature data ...

Data sources Six databases, six trial registries and prior systematic reviews. Forward and backward citation tracking was employed. Eligibility criteria Randomised controlled trials that compared ...

Can you give a brief overview of Lonza, the markets you serve and the types of products that you produce? Lonza is a large, multinational corporation serving the entire pharmaceutical product ...